|
|
| Our research program "Examination of effectiveness in Acute Lung Injury
by the administration of human recombinant Thioredoxin" was adopted the
new public grant (2003 - 2005), made by Ministry of Education, Culture,
Sports, Science and Technology. (2003.8.6.) new
Open Competition for the Development of Innovative Technology |
| “Thioredoxin Project” was selected as an invited research project in Translational Research Center, Kyoto University Hospital on June 1st, 2003. Professor Junji Yodoi in Institute for Virus Research, Kyoto University is the project leader. This project aims to do clinical trial to see the effects of recombinant human thioredoxin on patients with acute respiratory distress syndrome/acute lung injury. Redox Bioscience, Inc. will support this project to promote our pharmaceutical development. |
| Industrial and academic organizations including our company jointly proposed the research program "Research and development of thioredoxin-based functional foods (2002 - 2006) ", and it was adopted in Bio-oriented Technology Research Advancement Institution (BRAIN). More... |
| Industrial and academic organizations including our company jointly proposed the research program as a consortium of local community economic development work "The project aims to develop rapid antibody assay micro chip system for human stress protein markers by combining research of thioredoxin (2002 - 2003) ", and it was accepted in Kansai Bureau of Economy, Ministry of Economy, Trade and Industry. More... |